Kalyan Pande obtained his PhD at the University of Wisconsin, Madison and conducted postdoctoral research at DNAX Inc. and at the University of California, San Francisco. He currently leads the Biologics Engineering and Exploration group at Merck South San Francisco. His team applies protein engineering technologies in the identification and validation of protein-based therapeutics across different therapeutic areas.